Shen, L., Zhang, X., Ji, K., Lu, L., Wang, Q., Guan, Q., Yan, S., Zhou, Y., Yang, Y., Huo, Z., You, J., Ba, Y., Ye, Y., Chen, Y., Wang, S., Lv, G., Zhang, J., Hu, X., Yang, F., Ji, J. (2026). Neoadjuvant/adjuvant serplulimab vs. placebo combined with chemotherapy for PD-L1–positive gastric cancer: A randomized, double-blind, multicenter phase 3 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4009